Exploring the links between sleep hygiene, muscle loss, and brain function in lung disease
Examination of the Relationship Between Sleep Hygiene, Sarcopenia, and Cognitive Function in Patients With Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis
This study looks at how good or bad sleep affects muscle loss and brain function in people with lung diseases like COPD and IPF.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | National Hospital Organization Minami Kyoto Hospital Academic / other |
| Locations | 1 site (Jōyō, Kyoto) |
| Trial ID | NCT05193136 on ClinicalTrials.gov |
What this trial studies
This observational study investigates how sleep hygiene affects the development of sarcopenia and cognitive dysfunction in patients with chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). It focuses on various sleep indicators such as sleep duration, arousal, and quality to understand their impact on disease progression and overall prognosis. By clarifying these relationships, the study aims to provide insights into the management of sleep-related disorders in these patient populations.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with COPD or IPF.
Not a fit: Patients who have been hospitalized for respiratory failure within the last month or those already diagnosed with sarcopenia or cognitive dysfunction may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for sleep hygiene that enhance muscle and cognitive function in patients with COPD and IPF.
How similar studies have performed: While the specific relationships being studied are not well understood, there is emerging interest in the connections between sleep disorders and sarcopenia or cognitive dysfunction, indicating potential for novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects with COPD or IPF. Exclusion Criteria: * Subjects who have been hospitalized for exacerbation of respiratory failure within 1 month of study participation * Subjects who have already been diagnosed with sarcopenia or cognitive dysfunction * Subjects receiving long-term oxygen therapy (LTOT) or non-invasive ventilation therapy (NIV) * Subjects with obstructive sleep apnea who are indicated for continuous positive airway pressure (CPAP) * Subjects with severe complications such as cardiovascular disease, liver disease, renal disease, malignancy, and neurological disease.
Where this trial is running
Jōyō, Kyoto
- National Hospital Organization Minami Kyoto Hospital — Jōyō, Kyoto, Japan (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.